Source: Nature Biotechnology – VOL38 – APRIL 2020
In the onslaught of the COVID-19 pandemic, the open sharing of materials, information and data is gaining increasing importance in biotech.
The coronavirus pandemic is posing profound challenges to our healthcare infrastructure, economic systems and social fabric. Many governments have been caught flat-footed, scrambling to ‘flatten the curve’ of community spread through social distancing or sheltering in place, as they attempt to maintain increasingly overwhelmed hospital services and mitigate shortages in medical supplies. The biotech industry is doing its part by fast tracking the production of diagnostics, rapidly repurposing existing treatments, and accelerating the discovery and development of new experimental therapeutics and vaccines that specifically target the virus.